# GRA Venture Fund

> GRA Venture Fund is a VC fund backing Health Care and Biotechnology. See 31 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Atlanta, United States
- Total investments: 31
- Last investment: Sep 2023
- Lead investor: 29%
- Fund size: $25M
- Last fund: Aug 2015
- Last updated: Aug 2026
- X (Twitter): http://twitter.com/ga_res_alliance
- Website: http://www.graventurefund.com
- Facebook: http://www.facebook.com/GeorgiaResearchAlliance

GRA Venture Fund is a VC fund in Atlanta focused on Health Care and Biotechnology. The GRA Venture Fund, LLC is a private investment fund helping to finance promising companies emerging from Georgia's universities. The Fund makes seed, early-stage, and mid-stage investments in companies originating from GRA Ventures, the commercialization arm of the Georgia Research Alliance. Fund investors are the State of Georgia, privateindividuals, corporations and foundations.

## Contacts

5 contacts available for GRA Venture Fund. Shizune tracks 1 team members at GRA Venture Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/gra-venture-fund-llc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 8 | 26% |
| Biotechnology | 8 | 26% |
| Medical | 3 | 10% |
| Software | 3 | 10% |
| Biopharma | 3 | 10% |

51 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 32% |
| Series A | 5 | 16% |
| Series B | 4 | 13% |
| Series C | 2 | 6% |
| Series D | 2 | 6% |

6 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| J. Connor Seabrook | Director, Investments and Venture Acceleration | 0 | https://shizune.co/investors/profile/j-connor-seabrook |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lucid Scientific | Lucid Scientific is a biotechnology tools company working to accelerate drug discovery and basic biological research by providing systems for real-time cellular analysis. It has invented an innovative new system for monitoring cell culture experiments. The company’s flagship technology, called RESIPHER, provides continuous and non-invasivemeasurement of oxygen consumption in a cell culture plate, then streams this information to a convenient web app. | $7M | Series A | Sep 05, 2023 |  |
| Micron Biomedical | Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market. The company was founded in 2014 and is based in Atlanta, Georgia. | $14M | Series A | Nov 25, 2022 |  |
| BioCircuit Technologies | BioCircuit Technologies develops noninvasive electrophysiology devices which monitor, control and repair peripheral nerves. ​ BioCircuit’s products provide clinicians with a practical ability to diagnose health conditions earlier, track the progression of symptoms over time, and select treatments more precisely for individual patients. | $9M | Seed | Sep 27, 2022 |  |
| Codoxo | Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $5.2M | Series B | Feb 03, 2022 |  |
| Codoxo | Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $5.2M | Series B | Feb 03, 2022 |  |
| Codoxo | Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $5.2M | Series B | Feb 03, 2022 |  |
| Antios Therapeutics | Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections.Antios Therapeutics was founded by Abel De La Rosa, DouglasMayers, and Idean Marvasty. | $75M | Series B | Nov 03, 2021 |  |
| Lucid Scientific | Lucid Scientific is a biotechnology tools company working to accelerate drug discovery and basic biological research by providing systems for real-time cellular analysis. It has invented an innovative new system for monitoring cell culture experiments. The company’s flagship technology, called RESIPHER, provides continuous and non-invasivemeasurement of oxygen consumption in a cell culture plate, then streams this information to a convenient web app. | $3M | Seed | Oct 01, 2020 |  |
| Codoxo | Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $7M | Series A | Jul 02, 2020 |  |
| Codoxo | Codoxo uses AI technology to re-envision healthcare affordability and effectiveness. Its Forensic AI Platform uses a patented algorithm to identify problems and suspicious behavior earlier than traditional techniques which helps ensure our scarce healthcare dollars go to real patient care. It was founded in 2016 and is based in Atlanta, Georgia. | $7M | Series A | Jul 02, 2020 |  |

10 of 31 investments shown.

## Co-investors
- [Spider Capital](https://shizune.co/investors/profile/spider-capital-partners) — VC Fund, 6 deals together
- [Brewer Lane Ventures](https://shizune.co/investors/profile/brewer-lane-ventures) — VC Fund, 5 deals together
- [QED Investors](https://shizune.co/investors/profile/qed-investors) — VC Fund, 5 deals together
- [TechSquare Labs](https://shizune.co/investors/profile/techsquare-labs) — VC Fund, 5 deals together
- [111° West Capital](https://shizune.co/investors/profile/111-west-capital) — VC Fund, 3 deals together
- [Imlay Investments](https://shizune.co/investors/profile/imlay-investments) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does GRA Venture Fund invest in?

GRA Venture Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Series A stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact GRA Venture Fund?

Public channels for GRA Venture Fund include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at GRA Venture Fund?

The team at GRA Venture Fund includes J. Connor Seabrook (Director, Investments and Venture Acceleration). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co